DZ3393A1 - Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite - Google Patents

Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite

Info

Publication number
DZ3393A1
DZ3393A1 DZ013393A DZ013393A DZ3393A1 DZ 3393 A1 DZ3393 A1 DZ 3393A1 DZ 013393 A DZ013393 A DZ 013393A DZ 013393 A DZ013393 A DZ 013393A DZ 3393 A1 DZ3393 A1 DZ 3393A1
Authority
DZ
Algeria
Prior art keywords
prophylaxis
obesity
detection
treatment
compounds suitable
Prior art date
Application number
DZ013393A
Other languages
English (en)
French (fr)
Inventor
Johannes Hebebrand
Jochen Antel
Ulf Freuschoff
Samuel David
Holger Sann
Michael Weske
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DZ3393A1 publication Critical patent/DZ3393A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DZ013393A 2000-07-20 2001-07-12 Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite DZ3393A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de) 2000-07-20 2001-07-12 Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (1)

Publication Number Publication Date
DZ3393A1 true DZ3393A1 (fr) 2002-01-31

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013393A DZ3393A1 (fr) 2000-07-20 2001-07-12 Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite

Country Status (26)

Country Link
EP (1) EP1307262B1 (cs)
JP (1) JP2004504053A (cs)
KR (1) KR100818827B1 (cs)
CN (1) CN1443085B (cs)
AR (1) AR028730A1 (cs)
AT (1) ATE278441T1 (cs)
AU (2) AU7753401A (cs)
BR (1) BR0112547A (cs)
CA (1) CA2416647A1 (cs)
CZ (1) CZ2003156A3 (cs)
DE (2) DE10035227A1 (cs)
DZ (1) DZ3393A1 (cs)
ES (1) ES2230346T3 (cs)
HU (1) HUP0302309A3 (cs)
IL (2) IL153971A0 (cs)
MX (1) MXPA02012907A (cs)
NO (1) NO20030233L (cs)
NZ (1) NZ523960A (cs)
PL (1) PL201165B1 (cs)
PT (1) PT1307262E (cs)
RU (1) RU2268721C2 (cs)
SK (1) SK287607B6 (cs)
TR (1) TR200402670T4 (cs)
TW (1) TWI274157B (cs)
UA (1) UA74588C2 (cs)
WO (1) WO2002007821A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1997370B (zh) 2004-05-19 2011-06-01 索尔瓦药物有限公司 N-氨磺酰-n＇-芳基哌嗪类化合物在制备用于预防或治疗肥胖和相关疾病的药物中的用途
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (ko) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
AR057570A1 (es) 2005-11-14 2007-12-05 Solvay Pharm Gmbh Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
EA200870556A1 (ru) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
JP5301465B2 (ja) 2007-01-25 2013-09-25 バーバ・ファーマシューティカルズ・リミテッド インスリン抵抗性改善薬および治療方法
EA018567B1 (ru) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US20150150855A1 (en) * 2012-05-24 2015-06-04 Verva Pharmaceuticals Ltd Method of improving liver function
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
ZA932660B (en) * 1992-04-17 1993-10-26 Sankyo Co Derivatives of adipogenesis inhibitory factor, their preparation and their use
TJ286B (en) * 1992-10-29 2000-12-13 Genentech Inc A method for treatment or prevention of obesity
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
RU2214241C2 (ru) * 1996-06-28 2003-10-20 Орто-Макнейл Фармасьютикал, Инк. Способ лечения ожирения и способ индуцирования потери веса у млекопитающих
US5727570A (en) * 1996-11-14 1998-03-17 Clemens; Anton H. Method of treating hyperlipidemia in humans
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
PT1307262E (pt) 2004-12-31
AR028730A1 (es) 2003-05-21
NO20030233L (no) 2003-03-19
SK612003A3 (en) 2003-06-03
KR100818827B1 (ko) 2008-04-01
RU2268721C2 (ru) 2006-01-27
CZ2003156A3 (cs) 2003-06-18
EP1307262A1 (de) 2003-05-07
IL153971A0 (en) 2003-07-31
NZ523960A (en) 2004-12-24
WO2002007821A1 (de) 2002-01-31
PL363518A1 (en) 2004-11-29
PL201165B1 (pl) 2009-03-31
HK1057499A1 (zh) 2004-04-08
SK287607B6 (sk) 2011-03-04
BR0112547A (pt) 2003-07-01
AU7753401A (en) 2002-02-05
ATE278441T1 (de) 2004-10-15
ES2230346T3 (es) 2005-05-01
IL153971A (en) 2009-07-20
AU2001277534B2 (en) 2005-09-29
CN1443085A (zh) 2003-09-17
HUP0302309A2 (hu) 2003-11-28
NO20030233D0 (no) 2003-01-17
MXPA02012907A (es) 2003-09-22
JP2004504053A (ja) 2004-02-12
TWI274157B (en) 2007-02-21
DE10035227A1 (de) 2002-01-31
HUP0302309A3 (en) 2005-06-28
KR20030022284A (ko) 2003-03-15
TR200402670T4 (tr) 2004-11-22
DE50104023D1 (de) 2004-11-11
AU2001277534B9 (en) 2006-02-23
CN1443085B (zh) 2010-04-28
UA74588C2 (en) 2006-01-16
CA2416647A1 (en) 2003-01-20
EP1307262B1 (de) 2004-10-06

Similar Documents

Publication Publication Date Title
DZ3393A1 (fr) Procede de detection de composes apropries pour le traitement et/ou la prophylaxie de l'obesite
FR2785521B1 (fr) Dispositif de suspension pour le traitement de prolapsus et d'incontinences urinaires
FR2781168B1 (fr) Procede et installation de traitement d'eau
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
MA26889A1 (fr) Composition pharmaceutique pour le traitement de la douleur aigue chronique et/ ou neuropathique et des migraines
MA25411A1 (fr) Microorganismes attenues pour le traitement d'infection.
EP1239855A4 (en) METHOD FOR PREVENTING AND TREATING ARTERIOSCLEROSIS
FR2775078B1 (fr) Procede et dispositif pour le traitement de vaisselle dans des lave-vaisselle
FR2733512B1 (fr) Procede pour inhiber ou retarder la formation, la croissance et/ou l'agglomeration des hydrates dans les effluents de production
FR2830962B1 (fr) Dispositif et methode de traitement d'image pour detection de lesions evolutives
EP1183030A4 (en) PROCESS FOR THE PREPARATION AND ITS USE OF N-DESMETHYLZOPICLONE
MA24437A1 (fr) Procede de la preparation et de la formulation de dihydrate d'eprosartan
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2785898B1 (fr) Procede et installation d'assainissement des eaux de bassins telles que les eaux de piscines
FR2818979B1 (fr) Procede de preparation d'imidaclopride
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
EP1161255A4 (en) METHOD AND MEANS FOR TREATING ERECTILE DYSFUNCTION
EP1339017A4 (en) NUCLEAR RANGE DETECTION METHOD AND NUCLEAR GENEALOGY PRODUCTION PROCESS
EP0743927A4 (en) Improved wastewater treatment process
EP1578723A4 (en) Process for the preparation of oxazolidinones and method of use thereof
FR2795398B1 (fr) Procede et installation pour le traitement d'effluents agricoles
FR2747947B1 (fr) Procede pour l'elimination des dechets animaux
FR2724376B1 (fr) Procede de traitement "in situ" des sediments et notamment des vases
FR2752834B1 (fr) Procede perfectionne pour conferer des proprietes hydrophobes aux surfaces d'articles siliceux